Ledger.Open graph →
SEC Form D · Amendment · filed September 20, 2018

Incysus Therapeutics, Inc

Offering
$10.0M
Sold
$8.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Frank H. Roessler · NEW YORK, NYDirectorRoger C. Freeman · Rye, NYDirectorThomas P. Salice · Rye, NYExec · DirectorSimon Quick Chapin Management QP, LLC · Morristown, NJDirectorRV Covington Manager, LLC · Atlanta, GAExec · DirectorMichael T. Biddulph · LONDON, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗